Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s) [NA]

View source ↗

Summary

An update on an ongoing clinical trial investigating early prostate cancer recurrence in patients with PSMA PET-positive unilateral pelvic lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Martini-Klinik am UKE GmbH | Conditions: Prostate Cancer | NA | Status: RECRUITING